SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability of the company’s lab-developed…
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
In 1970, the first cases of mpox were observed in the Democratic Republic of Congo, then spread to…